The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Efficacy and Safety of Epoetin Alfa in Critically Ill Patients
Open accessAbstract
BACKGROUND: Anemia, which is common in the critically ill, is often treated with red-cell transfusions, which are associated with poor clinical outcomes. We hypothesized that therapy with recombinant human erythropoietin (epoetin alfa) might reduce the need for red-cell transfusions. METHODS: In this prospective, randomized, placebo-controlled trial, we enrolled 1460 medical, surgical, or trauma patients between 48 and 96 hours after admission to the intensive care unit. Epoetin alfa (40,000 U) or placebo was administered weekly, for a maximum of 3 weeks; patients were followed for 140 days. The primary end point was the percentage of patients who received a red-cell transfusion. Secondary end points were the number of red-cell units transfused, mortality, and the change in hemoglobin concentration from baseline. RESULTS: As compared with the use of placebo, epoetin alfa therapy did not result in a decrease in either the number of patients who received a red-cell transfusion (relative risk for the epoetin alfa group vs. the placebo group, 0.95; 95% confidence interval [CI], 0.85 to 1.06) or the mean (+/-SD) number of red-cell units transfused (4.5+/-4.6 units in the epoetin alfa group and 4.3+/-4.8 units in the placebo group, P=0.42). However, the hemoglobin concentration at day 29 increased more in the epoetin alfa group than in the placebo group (1.6+/-2.0 g per deciliter vs. 1.2+/-1.8 g per deciliter, P<0.001). Mortality tended to be lower at day 29 among patients receiving epoetin alfa (adjusted hazard ratio, 0.79; 95% CI, 0.56 to 1.10); this effect was also seen in prespecified analyses in those with a diagnosis of trauma (adjusted hazard ratio, 0.37; 95% CI, 0.19 to 0.72). A similar pattern was seen at day 140 (adjusted hazard ratio, 0.86; 95% CI, 0.65 to 1.13), particularly in those with trauma (adjusted hazard ratio, 0.40; 95% CI, 0.23 to 0.69). As compared with placebo, epoetin alfa was associated with a significant increase in the incidence of thrombotic events (hazard ratio, 1.41; 95% CI, 1.06 to 1.86). CONCLUSIONS: The use of epoetin alfa does not reduce the incidence of red-cell transfusion among critically ill patients, but it may reduce mortality in patients with trauma. Treatment with epoetin alfa is associated with an increase in the incidence of thrombotic events. (ClinicalTrials.gov number, NCT00091910 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
(1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401322 · Cited by 2,037
Anemia and Blood Transfusion in Critically Ill Patients
Vincent, J. L. (2002) · JAMA · doi:10.1001/jama.288.12.1499 · Cited by 1,821
Corwin, H. L., Gettinger, A., Pearl, R. G., Fink, M. P., Levy, M. M., Abraham, E., MacIntyre, N. R., Shabot, M. M., Duh, M.-S., & Shapiro, M. J. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000104112.34142.79 · Cited by 1,348
Self-citationHenke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Effect of Stored-Blood Transfusion on Oxygen Delivery in Patients With Sepsis
Marik, P. E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500230106037 · Cited by 812
Leyland-Jones, B., Semiglazov, V., Pawlicki, M., Pienkowski, T., Tjulandin, S., Manikhas, G., Makhson, A., Roth, A., Dodwell, D., Baselga, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.150 · Cited by 668
Phrommintikul, A., Haas, S. J., Elsik, M., & Krum, H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60194-9 · Cited by 638
Bohlius, J., Wilson, J., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S., Djulbegovic, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 548
New Avenues of Exploration for Erythropoietin
Maiese, K. (2005) · JAMA · doi:10.1001/jama.293.1.90 · Cited by 528
Corwin, H. L., Gettinger, A., Pearl, R. G., Fink, M. P., Levy, M. M., Shapiro, M. J., Corwin, M. J., Colton, T., & for the EPO Critical Care Trials Group (2002) · JAMA · doi:10.1001/jama.288.22.2827 · Cited by 498
Self-citationCook, D., Crowther, M., Meade, M., Rabbat, C., Griffith, L., Schiff, D., Geerts, W., & Guyatt, G. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000171207.95319.b2 · Cited by 430
Corwin, H. L., Parsonnet, K. C., & Gettinger, A. (1995) · Chest · doi:10.1378/chest.108.3.767 · Cited by 358
Self-citationCorwin, H. L., Gettinger, A., Rodriguez, R. M., Pearl, R. G., Gubler, K. D., Enny, C., Colton, T., & Corwin, M. J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199911000-00004 · Cited by 351
Self-citationDiscovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise
Brines, M., & Cerami, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001546 · Cited by 290
Red blood cell transfusions and nosocomial infections in critically ill patients*
Taylor, R. W., O’Brien, J., Trottier, S. J., Manganaro, L., Cytron, M., Lesko, M. F., Arnzen, K., Cappadoro, C., Fu, M., Plisco, M. S., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000234034.51040.7f · Cited by 287
Rodriguez, R. M., Corwin, H. L., Gettinger, A., Corwin, M. J., Gubler, D., & Pearl, R. G. (2001) · Journal of Critical Care · doi:10.1053/jcrc.2001.21795 · Cited by 282
Self-citationErythropoietin response is blunted in critically ill patients
Rogiers, P., Zhang, H., Leeman, M., Nagler, J., Neels, H., Mélot, C., & Vincent, J.-L. (1997) · Intensive Care Medicine · doi:10.1007/s001340050310 · Cited by 272
Elevated Cardiac Troponin Measurements in Critically Ill Patients
Lim, W. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2446 · Cited by 195
Anemia of the critically ill: “Acute” anemia of chronic disease
Corwin, H. L., & Krantz, S. B. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00079 · Cited by 160
Self-citationEfficacy of red blood cell transfusion in the critically ill
Napolitano, L. M., & Corwin, H. L. (2004) · Critical Care Clinics · doi:10.1016/j.ccc.2003.12.002 · Cited by 127
Self-citationFusté, B., Serradell, M., Escolar, G., et al. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613275 · Cited by 88
Töbü, M., Iqbal, O., Fareed, D., Chatha, M. P., Hoppensteadt, D., Bansal, V., & Fareed, J. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000304 · Cited by 82
Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?
Coleman, T. R., & Brines, M. L. (2004) · Critical Care · doi:10.1186/cc2897 · Cited by 80
Research works printed but not linked: 1
- 10.1001/jama.269.23.3024 · doi:10.1001/jama.269.23.3024
Cited by
Rossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,484
Spahn, D. R., Bouillon, B., Cerny, V., Duranteau, J., Filipescu, D., Hunt, B. J., Komadina, R., Maegele, M., Nardi, G., Riddez, L., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2347-3 · Cited by 1,269
Bohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M., Weingart, O., Kluge, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60502-x · Cited by 597
Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care*
Napolitano, L. M., Kurek, S., Luchette, F. A., Corwin, H. L., Barie, P. S., Tisherman, S. A., Hebert, P. C., Anderson, G. L., Bard, M. R., Bromberg, W., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b39f1b · Cited by 551
Self-citationLitton, E., Xiao, J., & Ho, K. M. (2013) · BMJ · doi:10.1136/bmj.f4822 · Cited by 394
Metadata
- Authors
- Corwin, H. L., Gettinger, A., Fabian, T. C., May, A., Pearl, R. G., Heard, S., An, R., Bowers, P. J., Burton, P., Klausner, M. A., & Corwin, M. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-09-06
- Volume
- 357
- Issue
- 10
- Pages
- 965-976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2170110528
- Cited by
- 545
- References
- 25
- FWCI
- 31.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.